OnCall

Best Practices for Bispecifics

Thu, 23 Jul 2026 09:00:00 -0400

In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about common challenges and best practices for bispecifics.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

Implementing Bispecifics in a Clinical Practice

Thu, 09 Jul 2026 09:00:00 -0400

In this episode, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about how to implement bispecifics in a clinical practice.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

Operationalizing Bispecifics in Practice

Thu, 25 Jun 2026 09:00:00 -0400

In this episode, sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they talk about how to implement bispecifics in your practice.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

The Basics of Bispecifics

Wed, 10 Jun 2026 14:00:00 -0400

In this episode sponsored by Amgen, Susan Britton, Director of Scientific Liaisons for Cencora's IntrinsiQ Specialty Solutions is joined by the American Oncology Network's Dr. Ralph Boccia and Vice President of Pharmacy Services at OneOncology Lisa Raff as they give an overview on the basics of bispecifics.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

Q1 2026 GPO Legislative Townhall

Thu, 07 May 2026 08:00:00 -0400

In this episode, we highlight a recent talk given by Joel White, Partner and Head of Health at Monument Advocacy. Topics in this episode include the 2026 legislative outlook, drug policy updates, market consolidation issues, and physician payment issues.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

Operationalizing Radiopharmaceuticals in Your Practice

Thu, 30 Apr 2026 09:00:00 -0400

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us a rundown on operationalizing radiopharmaceuticals in your practice.

That is a wrap on our radiopharmaceutical series and we are excited for you to hear our upcoming episodes on legislation and bispecifics. If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

Radiopharmaceuticals: Billing and Reimbursement

Thu, 23 Apr 2026 12:00:00 -0400

Radiopharmaceutical Landscape

Thu, 19 Mar 2026 11:00:00 -0400

In this episode, Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an overview on the landscape surrounding radiopharmaceuticals.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for any professional medical advice, legal advice, or clinical judgment. Views expressed are opinions only and not endorsed by Cencora or any of its affiliates. The opinions expressed are solely those of the author and may include certain marketing statements. The content of this presentation is owned or licensed by Cencora, and reproduction of the content is not permitted without Cencora's consent. Neither OnCall nor Cencora control the accuracy of any third-party information. Accessing any referenced site is subject to such site’s terms of use.

Introduction to Radiopharmaceuticals

Mon, 16 Feb 2026 10:00:00 -0500

In this episode, Cencora's Nancy Young, VP of Commercialization at Cencora and Juliet Roldan, Associate Director of Radiology Operations at American Oncology Network give us an introduction to the basics of radiopharmaceuticals.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Q4 2025 GPO Legislative Townhall

Thu, 08 Jan 2026 10:00:00 -0500

In this episode, Joel White, Partner and Head of Health at Monument Advocacy, talks about updates on DC legislative and regulatory issues, what to expect in 2026 for physician and hospital payments and the Rural Health fund, drug reimbursement and what to expect when IRA prices go live January 1, 2026, and Obamacare subsidies and what happens if they expire.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Q3 GPO Legislative Townhall

Thu, 09 Oct 2025 12:00:00 -0400

In this episode, Joel White, Partner and Head of Health Practice at Monument Advocacy, will discuss the Medicare physician fee schedule proposed rule and impact on practices and manufacturers, end of the year health priorities for congress, and Trump Administration goals, plans and efforts on drug pricing/MFN.

If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Inflation Reduction Act: Current State

Thu, 14 Aug 2025 12:00:00 -0400

In this episode, Whitley Quan, Manager of Cencora's U.S. Public Policy will be speaking on the current state of IRA implementation and what Cencora is doing to help its customer prepare for IRA deadlines.

For IRA specific questions, please reach out to IRAsupport@cencora.com. If you have any other questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Q2 GPO Legislative Townhall

Thu, 31 Jul 2025 09:00:00 -0400

In this episode, Joel White, President and CEO of Horizon Government Affairs will be speaking on budget bill and payment updates for physicians, CMMI reforms for value-based care, CMS focus on technology assisted care, and drug price reforms.

If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

Inflation Reduction Act: Overview

Tue, 22 Jul 2025 11:00:00 -0400

In this episode, the first of our new Inflation Reduction Act series, Cencora's VP of Market Economics, Tyler Novotny, and Megan Law, Sr. Director of Specialty GPO Portfolio Accounts, will give an overview of IRA and dive into IRA impact on patients, manufacturers, and providers.

If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

505(b)(2) Operationalizing in Practice - Provider Perspective

Tue, 13 May 2025 17:00:00 -0400

In this episode, the final of our 505(b)(2) series, sponsored by Avyxa, we are joined by Dr. Fred Divers, Chief Medical Officer for American Oncology Network, and Dr. Ralph Boccia, hematologist oncologist, member of American Oncology Network, and the International Oncology Network's Chief Medical Officer, who will discuss operationalizing in practice from a provider perspective.

If you have questions for our guests, or suggestions for future topics, email us at OnCall@cencora.com.

505(b)(2) Operationalizing in Practice - Pharmacist Perspective

Thu, 01 May 2025 09:00:00 -0400

In this episode, the fourth of our 505(b)(2) series, sponsored by Avyxa, we are joined by James Gilmore, Chief Pharmacy and Clinical Services Officer at American Oncology Network, and Joe Shupp, VP of Sales for Cencora's ION Oncology Network, who will discuss operationalizing in practice from a pharmacist perspective.

If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.

505(b)(2) Billing and Reimbursement

Thu, 17 Apr 2025 10:00:00 -0400

In this episode, the third of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Trey McNiel, Senior Director of Sales for Cencora's ION Oncology Network East Region, discuss billing and reimbursement of 505(b)(2)s.

If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.

505(b)(2) Landscape and Pipeline

Thu, 03 Apr 2025 11:00:00 -0400

In this episode, the second of our 505(b)(2) series, sponsored by Avyxa, we are joined by Jonas Congelli, Chief Strategy Officer at Hematology-Oncology Associates of Central New York, Kyle Kitchen, Senior Director at Utah Cancer Specialists, and Matthew Letow, Senior Director of Sales New Business Development for Cencora's SAN GPO National Accounts, who will discuss the landscape and pipeline of 505(b)(2)s.

If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.

505(b)(2) Basics

Tue, 18 Mar 2025 13:00:00 -0400

In this episode, the first of our 505(b)(2) series, sponsored by Avyxa, we are joined by Zach Horstman, Director of Specialty GPO Corporate Accounts for Cencora, and Yoni Resnick, Director of Pharmacy Clinical Services at New England Cancer Specialists, who will discuss the basics of 505(b)(2)s.

If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.

Buy and Bill: Practice Perspective

Tue, 04 Feb 2025 14:00:00 -0500

In this episode, we are joined by Cencora's Specialty Practice Network National Senior Director of Sales for Immunology, Chara Reid, VP Sales for Cencora's Specialty Practice Network, Kortney Cooper, and Elizabeth Johnson, CEO of MedicoCX, who will discuss how buy and bill is implemented in MedicoCX practices.

If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed by Cencora or affiliates. Neither OnCall nor Cencora control the accuracy of third party information. Accessing those sites is at your own risk and subject of their terms of use.

Buy and Bill: The Basics

Wed, 22 Jan 2025 15:00:00 -0500

In this episode, we are joined by Kortney Cooper, VP of Sales for Cencora's Specialty Practice Network, who will discuss the basics of buy and bill.

To find a copy of Kortney's presentation, please visit our OnCall page under Clinical Education on our ION and Specialty Practice Network websites.

If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed by Cencora or affiliates. Neither OnCall nor Cencora control the accuracy of third party information. Accessing those sites is at your own risk and subject of their terms of use.

GPO 101: Legislative Townhall

Wed, 08 Jan 2025 15:00:00 -0500

In this episode, we are joined by Joel White, President of Horizon Government Affairs, who will discuss the Inflation Reduction Act, PBM reform, drug shortages, Medicare physician payment and telehealth issues.

If you have questions for our guests or suggestions for future topics, send us an email at OnCall@cencora.com.

Disclaimer: The OnCall podcast is for educational purposes only and not a substitute for professional medical advice or clinical judgement. Views expressed are opinions only and not endorsed by Cencora or affiliates. Neither OnCall nor Cencora control the accuracy of third party information. Accessing those sites is at your own risk and subject of their terms of use.

Biosimilar Basics: Payer Perspective

Wed, 19 Jun 2024 12:00:00 -0400

In this episode, the fourth of our Biosimilars series, Christie Smith discusses the biosimilar payer perspective.

If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Biosimilar Basics: Legislation

Thu, 23 May 2024 12:00:00 -0400

In this episode, the third of our Biosimilars series, Corey Ford, Vice President of Reimbursement and Policy Insights, and Cristina Muñoz, Senior Director of Head of State Government Advocacy discuss legislation surrounding biosimilars.

Our next episode will feature information on the biosimilar payer perspective. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Biosimilar Basics: Market Landscape

Wed, 01 May 2024 15:00:00 -0400

In this episode, the second of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss the current Biosimilar landscape and what we can expect to see in the market.

Our next episode will feature information on biosimilar legislation. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Biosimilar Basics: Overview

Wed, 17 Apr 2024 11:00:00 -0400

In this episode, the first of our Biosimilars series, Brian Biehn, Senior Director of Biosimilar Injectables, and Connor Nell, Director of Commercialization Injectables discuss Biosimilars 101 and resources to utilize to stay better informed.

Our next episode will feature information on the current Biosimilar landscape and what we can expect to see in the market. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall December 2023: Part 11

Thu, 08 Feb 2024 10:00:00 -0500

In this episode, the eleventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses drug pricing and shortages.

If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall December 2023: Part 10

Thu, 08 Feb 2024 09:00:00 -0500

In this episode, the tenth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses transparency in the House, competition, and lower costs on drugs and services.

Our next episode will feature information on drug pricing and shortages. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall December 2023: Part 9

Thu, 11 Jan 2024 10:00:00 -0500

In this episode, the ninth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses health issues around Medicare physician payment, and PBM reform.

Our next episode will feature information on transparency in the House, competition, and lower costs on drugs and services. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall August 2023: Part 8

Wed, 29 Nov 2023 14:00:00 -0500

In this episode, the eighth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses MPFS, Medicare Drug Price Negotiations, PBM reform, and elections.

That's all for this episode of OnCall. Our next episode will feature information on politics and policy, and physician payment issues. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall August 2023: Part 7

Thu, 07 Sep 2023 12:00:00 -0400

In this episode, the seventh of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses Congress and the fiscal backdrop.

Our next episode will feature information on issues regarding MPFS, Medicare Drug Price Negotiations, PBM reform, and elections. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall May 2023: Part 6

Thu, 17 Aug 2023 11:00:00 -0400

In this episode, the sixth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the new DEA proposed rules on prescribing controlled substances and treatments.

Our next episode will feature information on payment updates for Medicare. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall May 2023: Part 5

Tue, 01 Aug 2023 11:00:00 -0400

In this episode, the fifth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses the End of the Public Health Emergency and what it means for practices.

Our next episode will feature information on the New DEA proposed rules on prescribing controlled substances and treatments. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall May 2023: Part 4

Thu, 20 Jul 2023 10:00:00 -0400

In this episode, the fourth of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs discusses federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA.

Our next episode will feature information on the end of the Public Health Emergency and what it means for practices. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall Feb 2023: Part 3

Thu, 06 Jul 2023 15:00:00 -0400

In this episode, the third of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss the Inflation Reduction Act, PBM reform, and 2023 regulations.

Our next episode will feature information on federal budget and debt negotiations and the implications for Medicare, Medicaid and ACA. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall Feb 2023: Part 2

Thu, 22 Jun 2023 11:00:00 -0400

In this episode, the second of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss drug coverage, pricing, and payment.

Our next episode will feature information on the Inflation Reduction Act, PBM reform, and 2023 regulations. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

GPO Legislative Townhall Feb 2023: Part 1

Wed, 07 Jun 2023 14:00:00 -0400

In this episode, the first of our GPO Legislative Updates series, Joel White, President and CEO of Horizon Government Affairs, and Tony Lee discuss three important policy trends impacting physicians: Medicare payments, drugs/biologics, and disparities/SDOH.

Our next episode will feature information on drug coverage, pricing, and payments. If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Operational Pathways for Biomarker Testing in NSCLC

Tue, 21 Mar 2023 16:00:00 -0400

In this Amgen sponsored podcast, David R. Braxton, MD, Chief of Service for Molecular Pathology at Hoag Hospital, shares his insights as considerations on operationalizing biomarker testing into clinical practice in NSCLC. He discusses considerations on improving the turnaround time of test results, clinical application of ctDNA testing as well as strategies for documentation of results for ease of retrieval.

Sponsored by Amgen

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Biosimilar Series: Part 5

Wed, 21 Sep 2022 18:00:00 -0400

In this episode, the fifth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about operationalizing biosimilars into practice and the differences and similarities of this process for biosimilars versus their counterparts.

If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Biosimilar Series: Part 4

Fri, 09 Sep 2022 10:00:00 -0400

In this episode, the fourth of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the role of the payer in relation to biosimilars, the formulary management process and the differences in treatment of biosimilars by Medicaid and Medicare.

If you have any questions for our guests or have a topic you would like to learn more about, email us at OnCall@cencora.com.

Biosimilar Series: Part 3

Wed, 24 Aug 2022 11:00:00 -0400

In this episode, the third of our biosimilar education series, Neil Udovich spoke with Kathy Oubre, CEO of Pontchartrain Cancer Center, about the FDA approval process for biosimilars, the Biologics Price Competition and Innovation Act and safety issues or adverse effects related to biosimilar use.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Biosimilar Series: Part 2

Fri, 01 Jul 2022 10:00:00 -0400

In this episode, the second of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss the history of biosimilars, the reception of them in the medical community and their road ahead.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Biosimilar Series: Part 1

Thu, 30 Jun 2022 06:00:00 -0400

In this episode, the first of our biosimilar education series, Kathy Oubre, CEO of Pontchartrain Cancer Center, and Neil Udovich, Vice President of Sales for AmerisourceBergen Specialty GPOs, discuss what biosimilars are (and aren’t), interchangeability with their reference products, and Kathy’s experience with adopting them into her practice.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Biomarkers: Emerging Targets and Technologies

Fri, 25 Mar 2022 11:00:00 -0400

In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the importance of emerging biomarkers to basket and umbrella trial designs.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

The content and information contained in this podcast is sponsored by Elevation Oncology. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of IntrinsiQ or Elevation Oncology.

Biomarker Testing: A Closer Look at When, Who, and How to Test

Fri, 11 Mar 2022 10:00:00 -0500

In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about biomarker testing in the community oncology setting - from the advantages and disadvantages of liquid biopsies to the benefits of ordering test panels.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

The content and information contained in this podcast is sponsored by Elevation Oncology. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of IntrinsiQ or Elevation Oncology.

Germline Genetic Testing

Mon, 07 Mar 2022 10:00:00 -0500

In this podcast series brought to you by Invitae, oncology specialists who routinely integrate genetic information into their patients' treatment, discuss actionable options for implementing genomics-informed, personalized cancer care.

In the first installment of this series, Dr. Rakesh Patel, Chief Medical Officer, Digital Health, and Dr. Peter Beitsch, Breast Surgical Oncologist, Past President of the American Society of Breast Surgeons, discuss common barriers for integrating genetic testing, and emerging digital health tools that can help health care practitioners scale the use of genomic information to help their patients.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

The content and information contained in this podcast is sponsored by Invitae. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of AmerisourceBergen or Invitae.

Buy and Bill 101: Part 4

Wed, 16 Feb 2022 06:00:00 -0500

In the final episode of our buy and bill series, we discuss reducing financial barriers for your patients and talk to Joe Baffone, CEO of Annexus Health, about the benefit of implementing efficient financial navigation programs within your practice.

Visit our website for more information or to become a member and ensure you have access to all of our product discounts and rebates, consulting services, upcoming and archived educational content, and all other benefits of a free GPO membership.

To learn more about our partners at Annexus Health, visit AnnexusHealth.com.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Buy and Bill 101: Part 3

Wed, 02 Feb 2022 06:00:00 -0500

In this episode, we talk about the reimbursement aspect of the buy and bill model and the four key issues that could negatively impact the health of your revenue cycle.

Click here to get in touch with us for more information on this or variety of other topics related to your specialty practice.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Biomarkers 101: Basics of Biomarker Testing

Fri, 21 Jan 2022 15:00:00 -0500

In this episode, a part of our biomarker testing series, we are joined by Dr. Manish Patel, Director of Drug Development for Florida Cancer Specialists, to talk about the basics of biomarker testing – from identifying common testing approaches to comparing DNA and RNA sequencing.

If you have any questions for today’s guest or have a topic you would like to learn more about, email us at OnCall@cencora.com.

The content and information contained in this podcast is sponsored by Elevation Oncology. This podcast is for educational, and informational purposes only. This podcast does not constitute medical or other professional advice or services. No person should act or refrain from acting on the basis of content provided in any podcast or website without first seeking appropriate medical advice and counseling. The opinions expressed in this podcast are the opinions of the individual and may not reflect the opinions of IntrinsiQ or Elevation Oncology.

Buy and Bill 101: Part 2

Wed, 19 Jan 2022 06:00:00 -0500

In this episode, we discuss the benefits of buy and bill, how to get reimbursed, steps to take for timely payment and the important role patient assistance plays to protect the practice from financial risk and protect your patients from financial toxicity.

Click here to get in touch with us for more information on this or variety of other topics related to your specialty practice.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Buy and Bill 101: Part 1

Fri, 14 Jan 2022 11:00:00 -0500

This is the first episode in our series covering buy and bill. As more drugs that utilize this payment model enter the market, we want to make sure you have the information needed for proper payment and reimbursement.

This type of education is just one essential benefit of a free GPO membership. In this episode, we cover the many advantages of a GPO membership and begin our overview of the buy and bill process.

Learn more about AmerisourceBergen Specialty GPOs.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Novel Agents and Toxicity Management 101

Mon, 08 Nov 2021 13:00:00 -0500

The rise of genomic sequencing and use of novel agents in the new standard of cancer care has created new challenges in recognizing and managing toxicities.

In this episode, we are joined by Dr. Ian Olver, medical oncologist, bioethicist, researcher and current Professorial Research Fellow in the School of Psychology at the University of Adelaide, to discuss strategies and tools to support community oncologists in keeping patients on effective drugs by better managing the associated toxicities.

Learn more about our partners at VieCure.

The content and information contained in this podcast is provided [exclusively or solely] by VieCure and AmerisourceBergen is not responsible and does not verify for accuracy any of the information contained in the podcast. The primary purpose of the podcast is to educate and inform. This podcast does not constitute medical or other professional advice or services.

Using AI Clinical Decision Support to Manage Cancer Complexity

Mon, 25 Oct 2021 16:00:00 -0400

The average oncologist would need 29 hours a day to keep up with the advances in cancer care. There are new treatments, policies, drugs, toxicities, trials—and a shortage of oncologists and nurses.

In this episode, we are joined by Dr. Fred Ashbury, co-founder and chief scientific officer at Viecure, to highlight the key areas where A.I. significantly improves your ability to treat patients effectively and efficiently while also adding value to your practice.

Learn more about our partners at VieCure.

The content and information contained in this podcast is provided [exclusively or solely] by VieCure and AmerisourceBergen is not responsible and does not verify for accuracy any of the information contained in the podcast. The primary purpose of the podcast is to educate and inform. This podcast does not constitute medical or other professional advice or services.

Paradigms, Policy and Pharmacogenomics: What community oncologists need to know

Mon, 11 Oct 2021 14:00:00 -0400

The evolution of cancer care is advancing so quickly, it’s nearly impossible to keep up. Genetic sequencing has radically improved our ability to get the right drug to the right patient—improving outcomes for both patients and practices. But policy is unclear, lab testing is interpreted differently, and funding is available—but how do you get it?

In this episode, we are joined by Dr. Howard McLeod (internationally recognized expert in precision medicine and medical director for precision medicine at the Geriatric Oncology Consortium) and Dr. Jai Patel (chair of the department of cancer pharmacology and pharmacogenomics at Atrium Health’s Levine Cancer Institute) who dive into the paradigm shift in cancer care, the role of genomic testing and sequencing, and navigating policy to your practice’s advantage.

Learn more about our partners at VieCure.

The content and information contained in this podcast is provided [exclusively or solely] by VieCure and AmerisourceBergen is not responsible and does not verify for accuracy any of the information contained in the podcast. The primary purpose of the podcast is to educate and inform. This podcast does not constitute medical or other professional advice or services.

Clinical trials: How has precision medicine elevated the role of community oncology?

Fri, 03 Sep 2021 08:00:00 -0400

Precision medicine is refocusing which clinical trials are possible, but we still have a ~5% participation rate and non-diverse patient demographic. Community oncology is the doorway to changing the face of clinical trials in the era of precision medicine. In this podcast, we talk about why, how and what’s in it for your practice to facilitate clinical trials in the community setting.

Learn more about our partners at VieCure.

Dr. Paul Bunn Jr., MD, FASCO: Dr. Bunn is a Distinguished Professor, VieCure Clinical Advisory Council Member, and James Dudley Endowed Chair in Lung Cancer Research Division of Medical Oncology University of Colorado.

Dr. Fred Ashbury, PhD, MACE: Dr. Ashbury is a co-founder and Chief Scientific Officer at VieCure. He is responsible for developing and maintaining VieCure’s oncology clinical content, genomic-science knowledge identification and codification, and the design and implementation of the treatment strategy rules that underpin our platform.

The content and information contained in this podcast is provided [exclusively or solely] by VieCure and AmerisourceBergen is not responsible and does not verify for accuracy any of the information contained in the podcast. The primary purpose of the podcast is to educate and inform. This podcast does not constitute medical or other professional advice or services.

Treating with TIBSOVO: A targeted therapeutic option for patients with R/R mIDH1 AML

Tue, 03 Aug 2021 14:00:00 -0400

Listen to a discussion between Jonathan Abbas, MD, and Mark Levis, MD, PhD.

Please listen to additional safety information for TIBSOVO® (ivosidenib tablets) at the end of this presentation. Please visit TibsovoPro.com to review the Full Prescribing Information, including BOXED WARNING.

Off Our Chests: A Discussion with Dr. John and Liza Marshall

Thu, 08 Jul 2021 07:00:00 -0400

In this episode, we met with Dr. John Marshall, a medical oncologist, Georgetown University professor and frequent guest speaker at ION Solutions events, and his wife, Liza Marshall, to discuss their book, “Off Our Chests: A Candid Tour Through the World of Cancer”.

To learn more or purchase a copy of the book, visit OffOurChestsBook.com.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

Precision Medicine Series: Evolution Part 2

Tue, 04 May 2021 10:00:00 -0400

In this episode Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, and Nicole Chambers, Senior Director of Corporate Services for ION Solutions, discuss the advancements in liquid and tissue biopsy testing as well as the improvements our partners are making in the precision medicine space.

If you have any questions for today’s guests or a topic you would like to learn more about, let us know at OnCall@cencora.com.

Precision Medicine Series: Evolution Part 1

Tue, 09 Mar 2021 14:00:00 -0500

In this episode, a part of our Precision Medicine series, Susan Weidner, Senior VP of IntrinsiQ Analytics, and Natasha Clinton, Director of Medical Affairs for IntrinsiQ Specialty Solutions, discuss the overall strategy for ION’s precision medicine program - from the creation of the Precision Medicine Advisory Panel to where we are headed in the future.

If you have any questions for today’s guests, or have a topic you would like to hear more about, email OnCall@cencora.com.

A Conversation with Annexus Health

Mon, 08 Mar 2021 14:00:00 -0500

In this extended episode, Brian Ansay, President of ION and IPN Solutions, sat down with Joe Baffone, Co-Founder and CEO of Annexus Health, to discuss our partnership and the exciting opportunities available to our members.

Reach out to your ION or IPN Solutions sales rep or visit the Annexus Health website to learn more.

We want to make sure you are getting the most out of our content, so if you have a topic you would like to learn more about, let us know at OnCall@cencora.com.

Precision Medicine Series: Precision Medicine Center

Fri, 11 Dec 2020 17:00:00 -0500

This is the first episode in what will be our ongoing Precision Medicine series in which we will touch on all aspects of this expanding field, particularly in its relation to community oncology practices.

Nicole Chambers, Senior Director of Corporate Services at ION Solutions, and Carol Riley, Practice Manager at St. Louis Cancer Care, will discuss the creation of the Precision Medicine Center, ION’s centralized library of Precision Medicine testing recommendations, and its regular use within the processes of one of our practices.

If you have any questions for today’s guests, or would like to receive a demo of the Precision Medicine Center, email OnCall@cencora.com. We also want to make sure you are getting the most out of our content, so if you have a topic you would like to learn more about, let us know.